Kepos Capital’s Boston Scientific BSX Stock Holding History

Kepos Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-24,808	Closed	-$1.01M	–	365
2019 Q3	$1.01M	Buy	+24,808	New	+$1.05M	0.1%	109
2019 Q2	–	Sell	-158,338	Closed	-$6.08M	–	316
2019 Q1	$6.08M	Buy	+158,338	New	+$6.05M	0.46%	57
2018 Q4	–	Sell	-152,364	Closed	-$5.87M	–	346
2018 Q3	$5.87M	Buy	152,364 +102,904	+208%	+$3.59M	0.3%	81
2018 Q2	$1.62M	Sell	49,460 -33,752	-41%	-$1.02M	0.08%	181
2018 Q1	$2.27M	Sell	83,212 -61,297	-42%	-$1.67M	0.13%	130
2017 Q4	$3.58M	Buy	+144,509	New	+$3.99M	0.32%	93

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Kepos Capital's BSX Position: Q4 2019 in Review

Kepos Capital sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 24,808 shares — an estimated $1.01M sold.

Kepos Capital first reported a position in BSX in Q4 2017 and held it in 6 quarters. The position peaked at $6.08M in Q1 2019. 853 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

Kepos Capital reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
Kepos Capital sold 24,808 Boston Scientific shares in Q4 2019, an estimated $1.01M.
Kepos Capital first reported a position in Boston Scientific in Q4 2017 and held it in 6 quarters.
Kepos Capital's Boston Scientific position peaked at $6.08M in Q1 2019.
853 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Kepos Capital's 13F filing for Q4 2019, filed 13 Feb 2020.